|
|
|
API Intelligence
Newport Vision CI™ is the critical competitive intelligence and global business development system from Thomson, the industry authority on the global generics market.
Created specifically to address the needs of research-based innovator, specialty and niche-brand pharmaceutical companies, Newport Vision CI™ ensures you don't miss the developing generic competition that can impact your sales, or the opportunity that can build on your strengths.
|
|
 |
- Sales, launch, approval and regulatory date for more than 10,000 launched products
- Unique, early API manufacturing intelligence
- Worldwide patent families and individual patents for more than 90 countries
- Comprehensive Supplementary Protection Certificate (SPC) data for Europe
- Projected loss of exclusivity dates for US, EU and Japanese markets
- Sales figures by molecule and by dosage form for major world market regions, including two-year sales history
- NEW Launched does and pack price data from over 65 markets, India and China recently added
- Paragraph IV patent challenges commentaries, including company identities, FTF and status of litigation for more than 100 active cases
- Product launch and first market authorization data, country-by-country
- Orange book approved dose forms, US Drug Master Files, EU Certificates of Suitability and FDA warning letters and issues
- Labelling and prescribing data for more than 1,800 unique products
- Chemical structure diagram and details of alternative structures for thousands of products
- Powerful indexing and searching of products according to FDA approved indication and technology class
- NEW Product search by CAS® Registry Number as well as by brand or API name
- NEW Target product search or target company search by Corporate Group Location
- NEW Target product search by number of Unexpired Orange Book Patents
- Profiles of more than 12,000 companies and corporate groups, including subsidiary, launch, approvals, regulatory filings and APIs manufactured
- Detailed manufacturing capabilities for an increasing number of sites
- Alerting on key changes in products and companies, including new regulatory filings and approvals
- Up-to-the-minute integrated news from Thomson Dialog®
- NEW Reports on various generic conferences
|
|
|
 |
Competitive intelligence and business intelligence departments — Quickly assess competitive landscape for individual products and groups of products, or across therapy areas, competitor products, and companies
Product management, lifecycle management teams — Improve planning and management of product life cycles by understanding the anticipated timing and intensity of generic competition
Legal, and intellectual property professionals — Detect and interpret early warning signs of patent challenges and patent circumvention attempts
Business development and licensing departments — Profile competitors, business partners, and candidate products for acquisition, alliances, licensing, or supply, and manufacture purposes
|
|
|
|
|
|
| Simple deployment across your enterprise | | |
- Easy-to-use web-based interface
- Zero-cost deployment with secure, confidential access
- Integrated on-line help, including full glossary and FAQs
- Comprehensive training and technical support
- Monthly intelligence updates
- Flexible licensing options
| | |
|
|
|
|
| Contact information | | | Thomson Reuters 215 Commercial Street Portland, Maine 04101 Phone: 207-871-9700 Fax: 207-871-9800 Email | | |
|
|
|
|
| Additional Newport Vision CI information | | | API Manufactures Click here to update your information Click here to download the latest Newport Vision CI fact sheet | | |
|
|
|
|
|